Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Iterum Therapeutics Plc (ITRM) is now available.
Sailaja Puttagunta M.D. will step down as Chief Medical Officer of Iterum Therapeutics plc on May 31, 2024, for personal reasons, not due to any conflict with the firm. She will continue to assist as a consultant during the regulatory review of the company’s new drug application. Dr. Steven Aronin will take over her responsibilities in leading the company’s development and regulatory activities.
For an in-depth examination of ITRM stock, go to TipRanks’ Stock Analysis page.